Urinary Bladder Paragangliomas

Analysis of Succinate Dehydrogenase and Outcome

Sounak Gupta, Jun Zhang, Michael Rivera, Lori A. Erickson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Paragangliomas of the urinary bladder can arise sporadically or as a part of hereditary syndromes including those with underlying mutations in the succinate dehydrogenase (SDH) genes, which serve as tumor suppressors. SDH deficiency can be screened for by absence of immunohistochemical detection of SDHB. In this study of 11 cases, clinical follow-up was available for 9/11 cases. The cases were reviewed and graded based on the grading system for adrenal pheochromocytomas and paragangliomas (GAPP) criteria. Immunohistochemistry was performed for Ki67 and SDHB. Proliferative index was calculated by quantification of Ki67-positive cells at hot spots. The medical record was accessed for documentation of germline SDH mutations. Urinary bladder paragangliomas had a female predilection (8/11 cases), and 5/11 cases exhibited metastatic behavior. Patients with metastatic disease tended to be younger (mean age 43 vs 49 years), have larger lesions (5.8 vs 1.5 cm), and presented with catecholamine excess (4/4 vs 2/6 patients with non-metastatic lesions). Patients with metastatic disease had a higher mean Ki67 proliferation rate (4.9 vs 1.3 %) and GAPP score (mean of 5.8 vs 3.8) (p = 0.01). IHC for SDHB expression revealed loss of expression in 2/6 cases of non-metastatic paragangliomas compared to 4/5 patients with metastatic paragangliomas. Interestingly, of these four patients, two had a documented mutation of SDHB, one patient had a SDHC mutation, and another patient had a history of familial disease without mutation analysis being performed. Our study, suggests that SDH loss was suggestive of metastatic behavior in addition to younger age at diagnosis, larger tumor size, and higher Ki67 proliferation rate and catecholamine type.

Original languageEnglish (US)
Pages (from-to)243-252
Number of pages10
JournalEndocrine Pathology
Volume27
Issue number3
DOIs
StatePublished - Sep 1 2016

Fingerprint

Paraganglioma
Succinate Dehydrogenase
Urinary Bladder
Mutation
Pheochromocytoma
Catecholamines
Documentation
Medical Records
Neoplasms
Immunohistochemistry
Genes

Keywords

  • Paraganglioma
  • Pheochromocytoma
  • SDH
  • Succinate dehydrogenase
  • Urinary bladder

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Pathology and Forensic Medicine
  • Endocrinology

Cite this

Urinary Bladder Paragangliomas : Analysis of Succinate Dehydrogenase and Outcome. / Gupta, Sounak; Zhang, Jun; Rivera, Michael; Erickson, Lori A.

In: Endocrine Pathology, Vol. 27, No. 3, 01.09.2016, p. 243-252.

Research output: Contribution to journalArticle

Gupta, Sounak ; Zhang, Jun ; Rivera, Michael ; Erickson, Lori A. / Urinary Bladder Paragangliomas : Analysis of Succinate Dehydrogenase and Outcome. In: Endocrine Pathology. 2016 ; Vol. 27, No. 3. pp. 243-252.
@article{94a470f064284a14be87a8d3f33cf931,
title = "Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome",
abstract = "Paragangliomas of the urinary bladder can arise sporadically or as a part of hereditary syndromes including those with underlying mutations in the succinate dehydrogenase (SDH) genes, which serve as tumor suppressors. SDH deficiency can be screened for by absence of immunohistochemical detection of SDHB. In this study of 11 cases, clinical follow-up was available for 9/11 cases. The cases were reviewed and graded based on the grading system for adrenal pheochromocytomas and paragangliomas (GAPP) criteria. Immunohistochemistry was performed for Ki67 and SDHB. Proliferative index was calculated by quantification of Ki67-positive cells at hot spots. The medical record was accessed for documentation of germline SDH mutations. Urinary bladder paragangliomas had a female predilection (8/11 cases), and 5/11 cases exhibited metastatic behavior. Patients with metastatic disease tended to be younger (mean age 43 vs 49 years), have larger lesions (5.8 vs 1.5 cm), and presented with catecholamine excess (4/4 vs 2/6 patients with non-metastatic lesions). Patients with metastatic disease had a higher mean Ki67 proliferation rate (4.9 vs 1.3 {\%}) and GAPP score (mean of 5.8 vs 3.8) (p = 0.01). IHC for SDHB expression revealed loss of expression in 2/6 cases of non-metastatic paragangliomas compared to 4/5 patients with metastatic paragangliomas. Interestingly, of these four patients, two had a documented mutation of SDHB, one patient had a SDHC mutation, and another patient had a history of familial disease without mutation analysis being performed. Our study, suggests that SDH loss was suggestive of metastatic behavior in addition to younger age at diagnosis, larger tumor size, and higher Ki67 proliferation rate and catecholamine type.",
keywords = "Paraganglioma, Pheochromocytoma, SDH, Succinate dehydrogenase, Urinary bladder",
author = "Sounak Gupta and Jun Zhang and Michael Rivera and Erickson, {Lori A.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1007/s12022-016-9439-2",
language = "English (US)",
volume = "27",
pages = "243--252",
journal = "Endocrine Pathology",
issn = "1046-3976",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Urinary Bladder Paragangliomas

T2 - Analysis of Succinate Dehydrogenase and Outcome

AU - Gupta, Sounak

AU - Zhang, Jun

AU - Rivera, Michael

AU - Erickson, Lori A.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Paragangliomas of the urinary bladder can arise sporadically or as a part of hereditary syndromes including those with underlying mutations in the succinate dehydrogenase (SDH) genes, which serve as tumor suppressors. SDH deficiency can be screened for by absence of immunohistochemical detection of SDHB. In this study of 11 cases, clinical follow-up was available for 9/11 cases. The cases were reviewed and graded based on the grading system for adrenal pheochromocytomas and paragangliomas (GAPP) criteria. Immunohistochemistry was performed for Ki67 and SDHB. Proliferative index was calculated by quantification of Ki67-positive cells at hot spots. The medical record was accessed for documentation of germline SDH mutations. Urinary bladder paragangliomas had a female predilection (8/11 cases), and 5/11 cases exhibited metastatic behavior. Patients with metastatic disease tended to be younger (mean age 43 vs 49 years), have larger lesions (5.8 vs 1.5 cm), and presented with catecholamine excess (4/4 vs 2/6 patients with non-metastatic lesions). Patients with metastatic disease had a higher mean Ki67 proliferation rate (4.9 vs 1.3 %) and GAPP score (mean of 5.8 vs 3.8) (p = 0.01). IHC for SDHB expression revealed loss of expression in 2/6 cases of non-metastatic paragangliomas compared to 4/5 patients with metastatic paragangliomas. Interestingly, of these four patients, two had a documented mutation of SDHB, one patient had a SDHC mutation, and another patient had a history of familial disease without mutation analysis being performed. Our study, suggests that SDH loss was suggestive of metastatic behavior in addition to younger age at diagnosis, larger tumor size, and higher Ki67 proliferation rate and catecholamine type.

AB - Paragangliomas of the urinary bladder can arise sporadically or as a part of hereditary syndromes including those with underlying mutations in the succinate dehydrogenase (SDH) genes, which serve as tumor suppressors. SDH deficiency can be screened for by absence of immunohistochemical detection of SDHB. In this study of 11 cases, clinical follow-up was available for 9/11 cases. The cases were reviewed and graded based on the grading system for adrenal pheochromocytomas and paragangliomas (GAPP) criteria. Immunohistochemistry was performed for Ki67 and SDHB. Proliferative index was calculated by quantification of Ki67-positive cells at hot spots. The medical record was accessed for documentation of germline SDH mutations. Urinary bladder paragangliomas had a female predilection (8/11 cases), and 5/11 cases exhibited metastatic behavior. Patients with metastatic disease tended to be younger (mean age 43 vs 49 years), have larger lesions (5.8 vs 1.5 cm), and presented with catecholamine excess (4/4 vs 2/6 patients with non-metastatic lesions). Patients with metastatic disease had a higher mean Ki67 proliferation rate (4.9 vs 1.3 %) and GAPP score (mean of 5.8 vs 3.8) (p = 0.01). IHC for SDHB expression revealed loss of expression in 2/6 cases of non-metastatic paragangliomas compared to 4/5 patients with metastatic paragangliomas. Interestingly, of these four patients, two had a documented mutation of SDHB, one patient had a SDHC mutation, and another patient had a history of familial disease without mutation analysis being performed. Our study, suggests that SDH loss was suggestive of metastatic behavior in addition to younger age at diagnosis, larger tumor size, and higher Ki67 proliferation rate and catecholamine type.

KW - Paraganglioma

KW - Pheochromocytoma

KW - SDH

KW - Succinate dehydrogenase

KW - Urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=84981267541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981267541&partnerID=8YFLogxK

U2 - 10.1007/s12022-016-9439-2

DO - 10.1007/s12022-016-9439-2

M3 - Article

VL - 27

SP - 243

EP - 252

JO - Endocrine Pathology

JF - Endocrine Pathology

SN - 1046-3976

IS - 3

ER -